Alirocumab Evaluated for Treatment of Homozygous Familial Hypercholesterolemia
March 31, 2020
Alirocumab significantly reduced low-density lipoprotein cholesterol in adults with homozygous familial hypercholesterolemia, according to phase 3 data.
Recent Content
Johnson & Johnson Announces COVID-19 Vaccine Candidate
March 30, 2020
Johnson & Johnson expects to initiate human clinical studies for its lead COVID-19 vaccine candidate by September 2020.
FDA Permits Emergency Use of Experimental Treatments for COVID-19
March 30, 2020
Chloroquine and hydroxychloroquine have been authorized to treat hospitalized patients with COVID-19.
FDA Issues Emergency Use Authorization for ‘Game Changer’ COVID-19 Test
March 30, 2020
Abbott’s ID NOW COVID-19 test is able to deliver results in as little as 5 minutes.
10 Facts About Varicella Zoster Virus
March 30, 2020
Things to know about the root cause of chickenpox and shingles
Coronavirus News Roundup: Inhaler Shortages, Updates on Potential Treatments
March 27, 2020
Here’s a roundup of the latest coronavirus-related news from this week.
FDA Approves Ozanimod for Relapsing Multiple Sclerosis
March 27, 2020
Officials with the FDA have granted approval to ozanimod (Zeposia, Bristol Myers Squibb) for the treatment of relapsing multiple sclerosis.
Gilead to Rescind Orphan Drug Status for Remdesivir, a Potential COVID-19 Treatment
March 27, 2020
Gilead has now asked the FDA to rescind its orphan drug status for the potential COVID-19 therapy.
Study Examines Wide Range of Potential Influenza-Related Complications
March 26, 2020
Health care providers should look out for more than just respiratory diagnoses in patients when it comes to influenza-associated complications, according to a recent study.
AMA, APhA, ASHP Issue Joint Statement on Use of Medications to Treat COVID-19
March 26, 2020
In a joint statement, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) have communicated concerns regarding the inappropriate ordering, prescribing, or dispensing of treatments for COVID-19.
